Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1948-1967
Published online before print March 21, 2007, doi: 10.1161/CIRCULATIONAHA.107.181946
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/14/1948    most recent
CIRCULATIONAHA.107.181946v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCrindle, B. W.
Right arrow Articles by Daniels, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCrindle, B. W.
Right arrow Articles by Daniels, S. R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Lipids
Right arrow AHA Statements and Guidelines

(Circulation. 2007;115:1948-1967.)
© 2007 American Heart Association, Inc.


AHA Scientific Statement

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents

A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing

Brian W. McCrindle, MD, MPH, Chair; Elaine M. Urbina, MD; Barbara A. Dennison, MD, FAHA; Marc S. Jacobson, MD, FAHA; Julia Steinberger, MD, MS; Albert P. Rocchini, MD, FAHA; Laura L. Hayman, PhD, RN, FAHA; Stephen R. Daniels, MD, PhD, FAHA

Despite compliance with lifestyle recommendations, some children and adolescents with high-risk hyperlipidemia will require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia. The purpose of this statement is to examine new evidence on the association of lipid abnormalities with early atherosclerosis, discuss challenges with previous guidelines, and highlight results of clinical trials with statin therapy in children and adolescents with familial hypercholesterolemia or severe hypercholesterolemia. Recommendations are provided to guide decision-making with regard to patient selection, initiation, monitoring, and maintenance of drug therapy.


Key Words: AHA Scientific Statements • lipids • pediatrics • drugs • hypercholesterolemia




This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
J. M. Lee, A. Gebremariam, P. Card-Higginson, J. L. Shaw, J. W. Thompson, and M. M. Davis
Poor Performance of Body Mass Index as a Marker for Hypercholesterolemia in Children and Adolescents
Arch Pediatr Adolesc Med, August 1, 2009; 163(8): 716 - 723.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S Marimuthu and B S Menon
Acanthosis nigricans
Arch. Dis. Child., June 1, 2009; 94(6): 477 - 477.
[Full Text] [PDF]


Home page
The Diabetes EducatorHome page
M. T. Robinson
Nutrition Evidence-Based Guidelines for Treating Hyperlipidemia in Children With Type 1 Diabetes: A Case Presentation
The Diabetes Educator, May 1, 2009; 35(3): 408 - 419.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
J. N. Liberman, J. E. Berger, and M. Lewis
Prevalence of Antihypertensive, Antidiabetic, and Dyslipidemic Prescription Medication Use Among Children and Adolescents
Arch Pediatr Adolesc Med, April 1, 2009; 163(4): 357 - 364.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Barra, G Gaeta, S Cuomo, P Guarini, M C Foglia, G Capozzi, C Materazzi, and M Trevisan
Early increase of carotid intima-media thickness in children with parental history of premature myocardial infarction
Heart, April 1, 2009; 95(8): 642 - 645.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. G. Magnussen, A. Venn, R. Thomson, M. Juonala, S. R. Srinivasan, J. S.A. Viikari, G. S. Berenson, T. Dwyer, and O. T. Raitakari
The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study.
J. Am. Coll. Cardiol., March 10, 2009; 53(10): 860 - 869.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. Manlhiot, P. Larsson, R. C. Gurofsky, R. W. Smith, C. Fillingham, N. A. Clarizia, N. Chahal, J. T. Clarke, and B. W. McCrindle
Spectrum and Management of Hypertriglyceridemia Among Children in Clinical Practice
Pediatrics, February 1, 2009; 123(2): 458 - 465.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes--2009
Diabetes Care, January 1, 2009; 32(Supplement_1): S13 - S61.
[Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
S. K. Pasquali and J. S. Li
Prevention of Future Cardiovascular Disease in High-Risk Pediatric Patients: A Role for Lipid Lowering Therapy?
Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 131 - 133.
[Full Text] [PDF]


Home page
PediatricsHome page
E. R. Cox, D. R. Halloran, S. M. Homan, S. Welliver, and D. E. Mager
Trends in the Prevalence of Chronic Medication Use in Children: 2002-2005
Pediatrics, November 1, 2008; 122(5): e1053 - e1061.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. van der Graaf, C. Cuffie-Jackson, M. N. Vissers, M. D. Trip, C. Gagne, G. Shi, E. Veltri, H. J. Avis, and J. J.P. Kastelein
Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia
J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1421 - 1429.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. R. Daniels, F. R. Greer, and N. Stettler
An Assessment of the New Lipid Screening Guidelines: In Reply
Pediatrics, October 1, 2008; 122(4): 906 - 907.
[Full Text] [PDF]


Home page
CLIN PEDIATRHome page
S. Miller, C. Manlhiot, N. Chahal, G. Cullen-Dean, L. Bannister, and B. W. McCrindle
Impact of Increasing Adiposity in Hyperlipidemic Children
Clinical Pediatrics, September 1, 2008; 47(7): 679 - 684.
[Abstract] [PDF]


Home page
PediatricsHome page
S. R. Daniels, F. R. Greer, and and the Committee on Nutrition
Lipid Screening and Cardiovascular Health in Childhood
Pediatrics, July 1, 2008; 122(1): 198 - 208.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
K. A. Matyka
Type 2 diabetes in childhood: epidemiological and clinical aspects
Br. Med. Bull., June 1, 2008; 86(1): 59 - 75.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Palinski and C. Napoli
Impaired Fetal Growth, Cardiovascular Disease, and the Need to Move on
Circulation, January 22, 2008; 117(3): 341 - 343.
[Full Text] [PDF]


Home page
CirculationHome page
J. Steinberger and A. S. Kelly
Challenges of Existing Pediatric Dyslipidemia Guidelines: Call for Reappraisal
Circulation, January 1, 2008; 117(1): 9 - 10.
[Full Text] [PDF]


Home page
CirculationHome page
C. G. Magnussen, O. T. Raitakari, R. Thomson, M. Juonala, D. A. Patel, J. S.A. Viikari, J. Marniemi, S. R. Srinivasan, G. S. Berenson, T. Dwyer, et al.
Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study
Circulation, January 1, 2008; 117(1): 32 - 42.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Tabas, K. J. Williams, and J. Boren
Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications
Circulation, October 16, 2007; 116(16): 1832 - 1844.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
P. Velasquez-Mieyer, C. P. Neira, R. Nieto, and P. A. Cowan
Review: Obesity and cardiometabolic syndrome in children
Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 61 - 81.
[Abstract] [PDF]


Home page
DOC NewsHome page
J. Hendry
Statins May Benefit Kids With Recalcitrant Lipids
DOC News, October 1, 2007; 4(10): 3 - 8.
[Full Text]


Home page
CirculationHome page
E. A. Stein
Statins and Children: Whom Do We Treat and When?
Circulation, August 7, 2007; 116(6): 594 - 595.
[Full Text] [PDF]


Home page
CirculationHome page
L. L. Hayman, J. C. Meininger, S. R. Daniels, B. W. McCrindle, L. Helden, J. Ross, B. A. Dennison, J. Steinberger, and C. L. Williams
Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth: A Scientific Statement From the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism
Circulation, July 17, 2007; 116(3): 344 - 357.
[Full Text] [PDF]


Home page
PediatricsHome page
US Preventive Services Task Force
Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement
Pediatrics, July 1, 2007; 120(1): e215 - e219.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. W. McCrindle and for the Writing Group
Summary of the American Heart Association's Scientific Statement on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 982 - 985.
[Full Text] [PDF]